|
AU6012696A
(en)
|
1995-06-14 |
1997-01-15 |
Aberdeen University |
Prognostic and therapeutic system for cancer
|
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
|
USRE38490E1
(en)
|
1995-11-16 |
2004-04-06 |
Baylor College Of Medicine |
Method for identifying metastatic sequences
|
|
US5712097A
(en)
|
1996-01-19 |
1998-01-27 |
The Johns Hopkins University School Of Medicine |
Tumor suppressor gene, DPC4
|
|
CA2261019A1
(en)
|
1996-07-15 |
1998-01-22 |
Mayo Foundation For Medical Education And Research |
Methods to detect hk2 polypeptides
|
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
|
US6190857B1
(en)
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
|
AU8403098A
(en)
|
1997-07-15 |
1999-02-10 |
Deaconess Hospital |
Reagents and methods for diagnosis and prognosis of proliferative disor ders
|
|
US20020165143A1
(en)
|
1997-12-03 |
2002-11-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
FI980488A7
(fi)
|
1998-03-04 |
1999-09-05 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
WO1999064626A2
(en)
|
1998-06-06 |
1999-12-16 |
Genostic Pharma Limited |
Probes used for genetic profiling
|
|
WO1999064627A2
(en)
|
1998-06-06 |
1999-12-16 |
Genostic Pharma Limited |
Probes used for genetic profiling
|
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
|
CA2702148C
(en)
|
1999-01-06 |
2014-03-04 |
Genenews Inc. |
Method of profiling gene expression in a human subject having an infectious disease
|
|
EP1151142A2
(en)
*
|
1999-01-28 |
2001-11-07 |
Gen-Probe Incorporated |
Nucleic acid sequences for detecting genetic markers for cancer in a biological sample
|
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
|
FI990382A0
(fi)
|
1999-02-23 |
1999-02-23 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
|
JP4590107B2
(ja)
|
1999-04-09 |
2010-12-01 |
中外製薬株式会社 |
新規胎児性遺伝子
|
|
US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
|
GB9926805D0
(en)
|
1999-11-13 |
2000-01-12 |
Zeneca Ltd |
Diagnostic methods
|
|
CA2397207C
(en)
*
|
2000-01-13 |
2013-12-03 |
Genentech, Inc. |
Novel stra6 polypeptides
|
|
US6448086B1
(en)
|
2000-01-18 |
2002-09-10 |
Diagnostic Systems Laboratories, Inc. |
Insulin-like growth factor system and cancer
|
|
US6566130B1
(en)
|
2000-01-28 |
2003-05-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Androgen-regulated gene expressed in prostate tissue
|
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
|
AU2002214576A1
(en)
|
2000-10-13 |
2002-04-22 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genes related to development of refractory prostate cancer
|
|
WO2002037113A2
(en)
|
2000-11-03 |
2002-05-10 |
Michael Giesing |
Clinical and functional validation of targets from disseminated cancer cells
|
|
AU2002251844A1
(en)
|
2001-02-02 |
2002-10-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
US20060088823A1
(en)
|
2001-03-29 |
2006-04-27 |
Brian Haab |
Microarray gene expression profiling in clear cell renal cell carcinoma : prognosis and drug target identification
|
|
US20040203012A1
(en)
|
2001-05-25 |
2004-10-14 |
Eleftherios Diamandis |
Method of detecting and monitoring prostate and ovarian cancers
|
|
WO2002101357A2
(en)
|
2001-06-10 |
2002-12-19 |
Irm Llc |
Molecular signatures of commonly fatal carcinomas
|
|
WO2003009814A2
(en)
|
2001-07-25 |
2003-02-06 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
|
US7700293B2
(en)
|
2001-08-02 |
2010-04-20 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US20100297657A1
(en)
|
2001-08-02 |
2010-11-25 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
|
US6964850B2
(en)
|
2001-11-09 |
2005-11-15 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
|
AU2002357747A1
(en)
|
2001-12-10 |
2003-06-23 |
Millennium Pharmaceuticals Inc. |
Novel genes encoding colon cancer antigens
|
|
US6949342B2
(en)
|
2001-12-21 |
2005-09-27 |
Whitehead Institute For Biomedical Research |
Prostate cancer diagnosis and outcome prediction by expression analysis
|
|
US20030215835A1
(en)
|
2002-01-15 |
2003-11-20 |
Zairen Sun |
Differentially-regulated prostate cancer genes
|
|
JP2005519606A
(ja)
*
|
2002-03-14 |
2005-07-07 |
エグゾニ・テラピューティック・ソシエテ・アノニム |
ヒトカリクレイン−２及びカリクレイン−３のバリアント並びにそれらの使用
|
|
AUPS187002A0
(en)
*
|
2002-04-22 |
2002-05-30 |
Queensland University Of Technology |
Condition-specific molecules and uses therefor
|
|
WO2004025258A2
(en)
|
2002-09-10 |
2004-03-25 |
Sydney Kimmel Cancer Center |
Gene segregation and biological sample classification methods
|
|
US20060051763A1
(en)
|
2002-09-25 |
2006-03-09 |
Anu-Maria Loukola |
Detection methods
|
|
WO2004053106A2
(en)
|
2002-12-05 |
2004-06-24 |
Regulome Corporation |
Profiled regulatory sites useful for gene control
|
|
EP1592809B1
(en)
|
2003-02-07 |
2013-04-10 |
Diagnocure Inc. |
Method to detect prostate cancer in a sample
|
|
WO2004077942A2
(en)
|
2003-02-28 |
2004-09-16 |
Genpath Pharmaceuticals, Incorporated |
Inducible prostate cancer model
|
|
JP2006523456A
(ja)
|
2003-04-15 |
2006-10-19 |
アバロン ファーマシューティカルズ，インコーポレイテッド |
分子細胞遺伝学的方法を用いる癌連鎖遺伝子および治療標的の確認
|
|
US7659062B2
(en)
*
|
2003-06-03 |
2010-02-09 |
The Board of Trustee of the University of Arkansas System |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
|
|
HUE050365T2
(hu)
|
2003-06-24 |
2022-09-28 |
Genomic Health Inc |
Rákkiújulás valószínûségének elõrejelzése
|
|
AU2004258085B2
(en)
*
|
2003-07-10 |
2010-05-27 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
|
US20070048738A1
(en)
|
2003-07-14 |
2007-03-01 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for diagnosis, staging and prognosis of prostate cancer
|
|
WO2005012875A2
(en)
|
2003-07-29 |
2005-02-10 |
Bristol-Myers Squibb Company |
Biomarkers of cyclin-dependent kinase modulation
|
|
AU2004298604B2
(en)
|
2003-12-15 |
2010-09-23 |
The Regents Of The University Of California |
Molecular signature of the PTEN tumor suppressor
|
|
KR20070052694A
(ko)
|
2004-01-09 |
2007-05-22 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
유전자 발현을 위한 세포-유형-특이적 패턴
|
|
GB0400976D0
(en)
|
2004-01-16 |
2004-02-18 |
Univ Cambridge Tech |
Methods of diagnosis
|
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
|
JP2005211023A
(ja)
|
2004-01-30 |
2005-08-11 |
Hayashibara Biochem Lab Inc |
腎細胞癌の転移若しくは再発の可能性を予測する方法
|
|
WO2005083128A2
(en)
|
2004-02-25 |
2005-09-09 |
University Of South Florida |
Methods for predicting cancer outcome and gene signatures for use therein
|
|
US20070224596A1
(en)
|
2004-04-09 |
2007-09-27 |
Mariana Nacht |
Compositions and methods for the modifying hypoxia induced gene regulation
|
|
ES2636470T3
(es)
|
2004-04-09 |
2017-10-05 |
Genomic Health, Inc. |
Marcadores de expresión génica para predecir la respuesta a la quimioterapia
|
|
WO2005111619A1
(en)
|
2004-04-29 |
2005-11-24 |
Marc Ramael |
Method and kit for detecting components in a sample
|
|
US10066268B2
(en)
|
2004-05-07 |
2018-09-04 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Methods of diagnosing or treating prostate cancer using the ERG gene, alone or in combination with other over or under expressed genes in prostate cancer
|
|
US20080318803A1
(en)
|
2004-05-27 |
2008-12-25 |
Vertex Pharmaceuticals |
Biomarkers for Monitoring Impdh Pathway Inhibition
|
|
JP2008502326A
(ja)
|
2004-06-03 |
2008-01-31 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
癌治療に対する反応を予測およびモニターする方法
|
|
WO2006005043A2
(en)
|
2004-06-30 |
2006-01-12 |
Cemines, Inc. |
Compositions and methods for detecting protein interactions with target dna sequences
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
CN101018874A
(zh)
|
2004-08-13 |
2007-08-15 |
千年药品公司 |
用于鉴定、评估、预防和治疗前列腺癌的基因、组合物、试剂盒和方法
|
|
US7572640B2
(en)
|
2004-09-28 |
2009-08-11 |
Singulex, Inc. |
Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
|
|
CA2585571C
(en)
*
|
2004-11-05 |
2020-01-21 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
|
EP1824995A2
(en)
|
2004-11-24 |
2007-08-29 |
St. George's Enterprises Limited |
Diagnosis of prostate cancer
|
|
EP1836313A4
(en)
|
2004-12-17 |
2010-06-30 |
Veridex Llc |
METHOD FOR ASSESSING PATIENTS WITH AKUTER MYELOIDER LEUKEMIA
|
|
US7943306B2
(en)
|
2005-01-12 |
2011-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene expression signature for prediction of human cancer progression
|
|
JP2008536480A
(ja)
|
2005-02-17 |
2008-09-11 |
ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド |
癌の同定、評価、予防、および治療用組成物、キット、および方法、ならびに癌の治療法
|
|
US7666595B2
(en)
*
|
2005-02-25 |
2010-02-23 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
|
AU2006234897A1
(en)
*
|
2005-03-16 |
2006-10-19 |
Sidney Kimmel Cancer Center |
Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
|
|
WO2006105642A1
(en)
|
2005-04-05 |
2006-10-12 |
British Columbia Cancer Agency |
Biomarkers for the detection of lung cancer and uses thereof
|
|
CA2604852A1
(en)
|
2005-04-15 |
2006-10-26 |
Oncomethylome Sciences, S.A. |
Methylation markers for diagnosis and treatment of cancers
|
|
US20080275652A1
(en)
|
2005-05-13 |
2008-11-06 |
Universite Libre De Bruxelles |
Gene-based algorithmic cancer prognosis
|
|
CA2608359A1
(en)
|
2005-05-13 |
2006-11-23 |
Duke University |
Gene expression signatures for oncogenic pathway deregulation
|
|
US20060292610A1
(en)
|
2005-06-06 |
2006-12-28 |
Regents Of The University Of Michigan |
Prognostic meta signatures and uses thereof
|
|
ES2624863T3
(es)
|
2005-06-08 |
2017-07-17 |
Millennium Pharmaceuticals, Inc. |
Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer
|
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
AU2006259583A1
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2814598A1
(en)
*
|
2005-09-12 |
2007-03-22 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
|
JP2009514555A
(ja)
|
2005-11-08 |
2009-04-09 |
ユークリッド ダイアグノスティックス リミテッド ライアビリティー カンパニー |
癌評価の遺伝子関連ＣｐＧアイランドのメチル化アッセイのための材料と方法
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
WO2007072225A2
(en)
|
2005-12-01 |
2007-06-28 |
Medical Prognosis Institute |
Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
KR20080080525A
(ko)
|
2005-12-08 |
2008-09-04 |
노파르티스 아게 |
유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
|
|
WO2007070621A2
(en)
|
2005-12-13 |
2007-06-21 |
Children's Medical Center Corporation |
Prognosis indicators for solid human tumors
|
|
WO2007075672A2
(en)
|
2005-12-23 |
2007-07-05 |
Lankenau Institute For Medical Research |
Prognostic cancer markers
|
|
NZ593226A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (efnb2) for colorectal cancer prognosis
|
|
ES2300176B1
(es)
*
|
2006-02-15 |
2009-05-01 |
Consejo Superior Investig. Cientificas |
Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo.
|
|
US20070218512A1
(en)
|
2006-02-28 |
2007-09-20 |
Alex Strongin |
Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
|
|
US7914988B1
(en)
|
2006-03-31 |
2011-03-29 |
Illumina, Inc. |
Gene expression profiles to predict relapse of prostate cancer
|
|
US20090098538A1
(en)
|
2006-03-31 |
2009-04-16 |
Glinsky Gennadi V |
Prognostic and diagnostic method for disease therapy
|
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
|
WO2007140352A2
(en)
|
2006-05-26 |
2007-12-06 |
Invitrogen Corporation |
Plasma membrane and secreted cancer biomarkers
|
|
EP2029020A4
(en)
|
2006-06-22 |
2010-04-21 |
Wisconsin Alumni Res Found |
USE OF STROMA COLLAGEN IN THE DIAGNOSIS AND CHARACTERIZATION OF BREAST CANCER
|
|
WO2008036717A2
(en)
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
|
WO2008048570A2
(en)
|
2006-10-16 |
2008-04-24 |
The Ohio State University Research Foundation |
Piwil2-related biomarkers and cell lines useful therewith
|
|
WO2008067065A2
(en)
*
|
2006-10-19 |
2008-06-05 |
Shiv Srivastava |
Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
|
|
WO2008058018A2
(en)
|
2006-11-02 |
2008-05-15 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
US20080254481A1
(en)
|
2006-11-13 |
2008-10-16 |
Invitrogen Corporation |
Methods and kits for detecting prostate cancer biomarkers
|
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
|
EP2099929A4
(en)
|
2006-12-06 |
2010-12-08 |
Avalon Pharmaceuticals |
ASSOCIATED WITH CANCER GENES AS A BIOMARKER TO MONITOR THE RESPONSE TO IMPDH INHIBITORS
|
|
AT504702A1
(de)
|
2006-12-22 |
2008-07-15 |
Arc Austrian Res Centers Gmbh |
Set von tumormarkern
|
|
EP2102356A2
(en)
|
2007-01-09 |
2009-09-23 |
Brystol-Myers Squibb Company |
Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in prostate cells
|
|
US20090047694A1
(en)
|
2007-08-17 |
2009-02-19 |
Shuber Anthony P |
Clinical Intervention Directed Diagnostic Methods
|
|
CA2680591A1
(en)
|
2007-03-15 |
2008-09-25 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
WO2008122447A2
(en)
|
2007-04-10 |
2008-10-16 |
Epigenomics Ag |
Dna methylation assay for the diagnosis or prognosis of medical conditions
|
|
EP2162552A4
(en)
|
2007-05-11 |
2010-06-30 |
Univ Johns Hopkins |
BIOMARKER FOR MELANOME
|
|
JP2010529834A
(ja)
|
2007-05-21 |
2010-09-02 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
癌遺伝子の発見のための組成物および方法
|
|
US20110136123A1
(en)
|
2007-08-15 |
2011-06-09 |
Universite De Sherbrooke |
Alternative splicing gene variants in cancer
|
|
WO2009049966A2
(en)
|
2007-09-07 |
2009-04-23 |
Universite Libre De Bruxelles |
Methods and tools for prognosis of cancer in her2+ patients
|
|
WO2009051734A1
(en)
|
2007-10-17 |
2009-04-23 |
The General Hospital Corporation |
Microchip-based devices for capturing circulating tumor cells and methods of their use
|
|
GB0721605D0
(en)
|
2007-11-02 |
2007-12-12 |
Cancer Rec Tech Ltd |
Prostrate cancer susceptibility screening
|
|
US20090123439A1
(en)
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
|
WO2009070767A2
(en)
|
2007-11-28 |
2009-06-04 |
Whitehead Institute For Biomedical Research |
Systemic instigation systems to study tumor growth or metastasis
|
|
EP2065474A1
(en)
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic response to endocrine treatment
|
|
EP2215251A2
(en)
|
2007-11-30 |
2010-08-11 |
Siemens Healthcare Diagnostics GmbH |
Method for predicting therapy responsiveness in basal like tumors
|
|
WO2009089521A2
(en)
|
2008-01-10 |
2009-07-16 |
Nuvera Biosciences, Inc. |
Predictors for evaluating response to cancer therapy
|
|
WO2009105154A2
(en)
|
2008-02-19 |
2009-08-27 |
The Jackson Laboratory |
Diagnostic and prognostic methods for cancer
|
|
WO2009105640A1
(en)
|
2008-02-22 |
2009-08-27 |
Virginia Commonwealth University |
Signatures associated with rejection or recurrence of cancer
|
|
US8067178B2
(en)
|
2008-03-14 |
2011-11-29 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
RU2015123307A
(ru)
|
2008-03-26 |
2015-11-27 |
Теранос, Инк. |
Способ и система для прогнозирования клинических исходов
|
|
EP2105511A1
(en)
|
2008-03-28 |
2009-09-30 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
|
|
WO2009124251A1
(en)
|
2008-04-03 |
2009-10-08 |
Sloan-Kettering Institute For Cancer Research |
Gene signatures for the prognosis of cancer
|
|
CA2719172C
(en)
|
2008-04-10 |
2020-08-25 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Prostate cancer-specific alterations in erg8 gene expression and detection and treatment methods based on those alterations
|
|
CA2722424A1
(en)
|
2008-04-25 |
2009-10-29 |
Integrated Bioscience Solutions, Llc |
Cytological methods for detecting cancer
|
|
US8093000B2
(en)
|
2008-05-09 |
2012-01-10 |
The Regents Of The University Of California |
Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
|
|
CA2724433A1
(en)
|
2008-05-14 |
2009-11-19 |
Eth Zuerich |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
|
|
JP2011523551A
(ja)
|
2008-05-15 |
2011-08-18 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
血管形成の調節の新規ターゲット
|
|
WO2009140741A1
(en)
|
2008-05-23 |
2009-11-26 |
The University Of Queensland |
Agents and methods for diagnosing the presence or risk of prostate cancer
|
|
GB0809689D0
(en)
|
2008-05-28 |
2008-07-02 |
Cancer Res Inst Royal |
Markers for prostate cancee
|
|
AU2009253675A1
(en)
|
2008-05-28 |
2009-12-03 |
Genomedx Biosciences, Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
US20090298082A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Klee George G |
Biomarker panels for predicting prostate cancer outcomes
|
|
WO2009149166A2
(en)
|
2008-06-03 |
2009-12-10 |
Children's Hospital Medical Center |
Methods and compositions for the diagnosis and treatment of proliferative disorders
|
|
WO2010003773A1
(en)
|
2008-06-16 |
2010-01-14 |
Siemens Medical Solutions Diagnostics Gmbh |
Algorithms for outcome prediction in patients with node-positive chemotherapy-treated breast cancer
|
|
EP2315858A2
(en)
|
2008-07-08 |
2011-05-04 |
Source Precision Medicine, Inc. |
Gene expression profiling for predicting the survivability of prostate cancer subjects
|
|
AU2009270851A1
(en)
|
2008-07-16 |
2010-01-21 |
Dana-Farber Cancer Institute, Inc. |
Signatures and PCDETERMINANTS associated with prostate cancer and methods of use thereof
|
|
AU2009274563A1
(en)
|
2008-07-21 |
2010-01-28 |
Texas A & M University |
Methods for diagnosis and prognosis of skin cancer
|
|
EP2324111B1
(en)
|
2008-09-10 |
2013-07-03 |
Life & Brain GmbH |
Peripheral zone tumor cells, methods for their preparation and use
|
|
DK2350316T3
(da)
|
2008-10-20 |
2014-05-05 |
Valipharma |
Fremgangsmåder og anvendelser der involverer genetiske aberrationer af nav3 og aberrerende ekspression af multiple gener
|
|
AU2009307651A1
(en)
|
2008-10-22 |
2010-04-29 |
Genentech, Inc. |
Prostate stem cells and uses thereof
|
|
US7888035B2
(en)
|
2008-10-30 |
2011-02-15 |
Caris Mpi, Inc. |
Methods for assessing RNA patterns
|
|
WO2010056351A2
(en)
|
2008-11-14 |
2010-05-20 |
Stc.Unm |
Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
|
|
WO2010056993A2
(en)
*
|
2008-11-14 |
2010-05-20 |
Emory University |
Prostate cancer biomarkers to predict recurrence and metastatic potential
|
|
GB0821787D0
(en)
|
2008-12-01 |
2009-01-07 |
Univ Ulster |
A genomic-based method of stratifying breast cancer patients
|
|
CN102308212A
(zh)
|
2008-12-04 |
2012-01-04 |
加利福尼亚大学董事会 |
用于确定前列腺癌诊断和预后的材料和方法
|
|
AU2010203825A1
(en)
|
2009-01-06 |
2011-07-21 |
Genomic Health, Inc. |
Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
|
|
WO2010080933A1
(en)
|
2009-01-07 |
2010-07-15 |
Myriad Genetics, Inc |
Cancer biomarkers
|
|
CA2749601C
(en)
|
2009-01-14 |
2020-07-21 |
Stephen M. Hewitt |
Ratio based biomarkers and methods of use thereof
|
|
JP2012515353A
(ja)
|
2009-01-15 |
2012-07-05 |
ラボラトリー コーポレイション オブ アメリカ ホールディングス |
Ｈｅｒ−２発現の測定による患者の反応を判定する方法
|
|
EP2233590A1
(en)
|
2009-01-28 |
2010-09-29 |
AIT Austrian Institute of Technology GmbH |
Methylation assay
|
|
CA2729593A1
(en)
|
2009-02-20 |
2010-08-26 |
John Wayne Cancer Institute |
B7-h3 as a biomarker for diagnosing the progression and early lymph node metastasis of cancer
|
|
WO2010099577A1
(en)
|
2009-03-04 |
2010-09-10 |
The University Of Queensland |
Cancer biomarkers and uses therefor
|
|
US8700789B2
(en)
|
2009-03-16 |
2014-04-15 |
Apple Inc. |
Accessory and mobile computing device communication using an application communication protocol
|
|
US8765383B2
(en)
|
2009-04-07 |
2014-07-01 |
Genomic Health, Inc. |
Methods of predicting cancer risk using gene expression in premalignant tissue
|
|
EP2241634A1
(en)
|
2009-04-16 |
2010-10-20 |
Université Libre de Bruxelles |
Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer
|
|
JP2012525818A
(ja)
|
2009-04-16 |
2012-10-25 |
ナショナル リサーチ カウンシル オブ カナダ |
腫瘍特性及びマーカーセットの同定のための方法、腫瘍分類、並びに癌のマーカーセット
|
|
WO2010127399A1
(en)
|
2009-05-06 |
2010-11-11 |
Walter And Eliza Hall Institute Of Medical Research |
Gene expression profiles and uses thereof
|
|
WO2010129965A1
(en)
|
2009-05-08 |
2010-11-11 |
The Regents Of The University Of California |
Cancer specific mitotic network
|
|
US20100303795A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Soerensen Karina Dalsgaard |
Marker of prostate cancer
|
|
NZ597655A
(en)
|
2009-07-08 |
2013-05-31 |
Worldwide Innovative Network |
Method for predicting efficacy of drugs in a patient
|
|
WO2011039734A2
(en)
|
2009-10-02 |
2011-04-07 |
Enzo Medico |
Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
|
|
MX337650B
(es)
|
2009-11-23 |
2016-03-14 |
Genomic Health Inc |
Metodos para predecir el desenlace clinico del cancer.
|
|
NZ600268A
(en)
|
2010-01-11 |
2014-08-29 |
Genomic Health Inc |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
|
IL243203A
(en)
|
2010-07-27 |
2017-04-30 |
Genomic Health Inc |
Method for using gene expression to determine prognosis of prostate cancer
|
|
WO2014108896A1
(en)
|
2013-01-08 |
2014-07-17 |
Marpe Technologies Ltd. |
Device and method for body moles mapping and tracking
|